Cancer News

How Can Focal Adhesion Kinase, Fibroblasts, and C-X-C Chemokine Help?

Apr 28, 2023 12:43:32 PM / by Stephanie

0 Comments

Focal Adhesion Kinase: Can Adding Fibroblasts and C-X-C Chemokine Help With Suppression? Arsen Osipov - Synopsis below extracted from the video transcript.

 

Read More

Next Oncology Expanded Phase 1 Program Cancer Drug Research in Dallas

Apr 27, 2023 11:48:35 AM / by Stephanie posted in Interview

0 Comments

Cancer Drug Research: Expanded Phase 1 Program to the Dallas Area Anthony Tolcher MD - Synopsis below extracted from the video transcript.

 

Read More

Long-Term SAR408701 Treatment in NSQ NSCLC CEACAM5 Safety and Efficacy

Apr 21, 2023 2:11:45 PM / by Stephanie posted in Lung Cancer EGFR

0 Comments

CEACAM5: Safety and Efficacy Outcome in Long-term Treatment with SAR408701 in Pts with NSQ NSCLC Prof Charles Ricordel - Synopsis below extracted from the video transcript.

 

Read More

CAR-T Cell Therapy for B-Cell Malignancies: A Longitudinal Study

Apr 20, 2023 2:42:49 PM / by Stephanie posted in Lymphoma

0 Comments

Chimeric Antigen Receptor T-Cell Therapy: A Longitudinal Study Connor Johnson MD - Synopsis below extracted from the video transcript.

"Chimeric Antigen Receptor T-Cell Therapy: A Longitudinal Study" by Dr. Connor Johnson provides an overview of the use of CAR-T cell therapy in treating patients with B-cell malignancies. CAR-T cell therapy involves re-engineering a patient's own immune cells to recognize and attack cancer cells. Dr. Johnson discusses his experience treating patients with CAR-T cell therapy and the results of a longitudinal study that followed patients over a period of several years.

Read More

DecisionRT Tool to Guide Endocrine Therapy after BCS for Breast Cancer

Apr 19, 2023 11:47:05 AM / by Stephanie

0 Comments

DCISionRT: Examining the Effectiveness of Adjuvant Endocrine Therapy for Breast Cancer Patients After BCS Chirag Shah MD
 - Synopsis below extracted from the video transcript.

 

Read More

Platinum Chemotherapy vs. Temozolomide/Capecitabine: Advanced GEPNENs

Apr 18, 2023 3:05:45 PM / by Stephanie posted in ASCO22

0 Comments

Platinum Chemotherapy: vs. Temozolomide/Capecitabine for Advanced GEPNENs: ECOG-ACRIN EA2142 Results Jennifer Eads MD - Synopsis below extracted from the video transcript.

 

Read More

Taking on KRAS in Lung Cancer: Promising Advances in Targeted Therapy

Apr 17, 2023 12:34:25 PM / by Jai Luo, MD

0 Comments

KRAS Lung Cancer: Taking on Goliath Discussion by Jai Luo MD
 - Synopsis below extracted from the video transcript.

 

Read More

Pathologic Complete Response: I-SPY2 Trial Insights

Apr 14, 2023 1:40:25 PM / by Laura Huppert, MD posted in ASCO22, Breast Cancer

0 Comments

Pathologic Complete Response: How can the I-SPY2 study results benefit patients with HR+ HER2- Breast Cancer? Laura Huppert MD - Synopsis below extracted from the video transcript.

 

Read More

T-Vec and Pembrolizumab Combination the Masterkey-115 Trial

Apr 13, 2023 1:41:11 PM / by Brian Gastman, MD

0 Comments

T-Vec: Plus Pembro in Advanced Melanoma Patients the MASTERKEY-115 Phase 2 Trial Brian Gastman MD - Synopsis below extracted from the video transcript.

 

Read More

Lisaftoclax for CLL/SLL: Monotherapy, Acalabrutinib, or Rituximab?

Apr 7, 2023 8:38:08 AM / by Matthew Davids, MD, MMSc posted in ASH, Chronic Lymphocytic Leukemia

0 Comments

Lisaftoclax (APG-2575): In CLL/SLL Treatment: Safety and Efficacy as Monotherapy or Combined with Acalabrutinib or Rituximab Matthew Davids MD - Synopsis below extracted from the video transcript.

 

Read More

Subscribe to Email Updates

Recent Posts